Benefits

Future Microbiome 2024 is the only event to deliver leading market intelligence and industry presentations on the latest microbiome research and development for advancing new therapeutics to treat human diseases.

 

Benefits of attending include:

• Two days of in-depth presentations revealing the latest market intelligence addressing the industry’s collective challenges by sharing results and experiences.
• Exclusive networking opportunity, a chance to engage with other professionals with shared challenges and experiences in this fast-developing sector.
• Updates on regional projects and research led by leading genomics experts detailing their experiences, findings, and new proposals.
• Technical presentations from across the industry showcase the latest results from recent tests and trials, technological developments, and new technical know-how.
• New case studies on specific examples from leading industry experts in microbiome and next-generation sequencing initiatives.
• Unique opportunity to integrate with a multitude of biotech and pharmaceutical companies and seek new opportunities in this evolving industry.

 

Attending this conference will enable you to:

• Understand the current market dynamics of genomics and the healthcare industry
• Learn how to develop strategies for the advancement of global healthcare using the latest technologies and techniques
• Hear the latest trends with an overview of the year and projections for the biotech and pharmaceutical industries
• Discuss innovations and technological developments in microbiome research
• Access different ideas and perspectives from a multitude of experts and allied industries, combining regional experiences

 

Who should attend?

This event aims at leading biotech and pharmaceutical companies along with government and policy think tanks seeking to learn more about the latest microbiome technologies and technical know-how for developing new microbiome-based medicines. Core attendees include CEOs, COOs, CFOs, Presidents, Vice Presidents, Directors, Heads of, Superintendents, Managers, and Stakeholders involved in:

 

Microbiome Research	Next-Generation Sequencing	Business Development
Genomics Research	Immuno-Oncology	Clinical Trials and Approvals
Translational Research	Biotechnology Research	Manufacturing Research & Innovation
Multiomics Research	Pathology	Research and Development
Clinical Diagnostics	Bio-Surveillance	Strategy, Projects, & Public Affairs
Companion Diagnostics	Spatial Biology	Sales and Marketing Initiatives
Clinical Trials	System Biology and Research	Legal and Regulatory
Bioinformatics	Precision Medicine	Equipment Certification Services
Molecular Medicine	Laboratory Equipment	News Reporting and Journalism

 

From the following industries and companies:

Biotechnology Companies	Genomic and Pathology Laboratories	Associations and Alliances
Pharmaceutical Companies	Clinical Research Organizations	Universities and Academia
Biopharmaceutical Companies	Precision Medicine Researchers	Research and Development
Diagnostic Companies	NGS Equipment Manufacturers	Government Agencies
Global Healthcare Providers	Omics Research Companies	Consultants and Advisors
Next-Generation Sequencing Companies	Spatial Biology Companies	Public Consultation Groups
Cancer Research & Treatment	Molecular Medicine Companies	Legal and Compliance Services
Translational Research Companies	Non-Governmental Organizations	News Reporters and Journalists

 

Book now
To secure your place at Future Microbiome 2024, or if you require more information, please contact delegates@iQ-Hub.com.